A case report and literature review describe acute myeloid leukemia developing 32 months into icotinib therapy for ...
Fintel on MSN
Tivic Health Systems, Inc. interim CEO Dean Zikria outlines strategic priorities and 30-day agenda
Tivic Health Systems, Inc. (disclosed in the filing as Valion Bio, Inc.) announced that Interim Chief Executive Officer Dean Zikria has established a strategic agenda following his first 30 days in ...
Zikria's strategic review has set a focused agenda built on three priorities: * Advancing the development of Entolimod and ...
In the early hours of February 5, 1989, three men entered a room known as the irradiation chamber at a factory near San ...
What If on MSN
What if all nuclear reactors exploded at once?
Right now, there are over 400 nuclear power plants operating in 20 countries. Could they be ticking time bombs, potentially ...
A case report describes a child with B-ALL who recovered from probable blinatumomab-associated lung injury and completed a ...
Neoplastic lesions mimicking cellulitis and erysipelas When observing redness, swelling, and warmth in the lower limbs, one ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in differentiated targeted ...
KRAS- and ALK-driven lung cancer models, supporting mutation-agnostic development as monotherapy and in combination with established ...
The Phase 1 study assesses a zirconium-89 imaging counterpart for safety and tumor uptake; lung models test ATNM-400 alone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results